Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. Its products include eye drops, contact lens care, dermal medicines, skin care, internal medicines, cold remedies, test kits, and denture cleansers. Its operations are carried out through the following segments: Japan, America, Europe, Asia, and Others. The company was founded by Anmin Yamada on February 22, 1899 and is headquartered in Osaka, Japan.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

About PuraCap™ Pharmaceutical LLC - PuraCap™ Pharmaceutical LLC is an emerging, fully-integrated pharmaceutical company with expertise in product development, manufacturing and bringing affordable, world-class quality pharmaceutical products to their customers. The PuraCap™ corporate structure supports their three-prong approach for global growth with dedicated companies in the areas of prescription brands, PuraCap™ Pharmaceutical LLC; prescription generics, PuraCap™ Laboratories Inc.; and OTC and Private Label products, PuraVation™ Pharmaceuticals Inc. For more information on PuraCap™ Pharmaceutical LLC, visit the company's website at http://www.PuraCap.com.

McNeil-PPC, Inc. manufactures pharmaceutical and personal care products. The company was founded on December 30, 1988 and is headquartered in Fort Washington, PA.

CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA

Nippon Zoki Pharmaceutical Co. Ltd. is a private company headquartered in Chuo-ku, Japan, that manufactures pharmaceutical products.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company’s most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), etrasimod (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn’s disease. In 2016 the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials.

Bausch & Lomb is a Canadian eye health products company based in Laval, Quebec, Canada. It is one of the world's largest suppliers of contact lenses, lens care products, pharmaceuticals, intraocular lenses, and other eye surgery products. The company was founded in Rochester, New York in 1853 by optician John Bausch and cabinet maker turned financial backer Henry Lomb. Until its sale in 2013, Bausch & Lomb was one of the oldest continually operating companies in the US.

Seattle Gummy Company is a specialty pharmaceutical company focusing on delivering active pharmaceutical ingredients (APIs) using innovative gummy (semi-solid chewable gel) formulations. Soft and chewable gummy formulation is a perfect delivery carrier for medications, especially for populations having problem swallowing pills and capsules. Children younger than 6 generally lack fully developed gag reflex and could not swallow solid dosage forms. In addition, one in every 25 adults in US has swallowing problems. Syrup is often gooey, hard to measure and prone to spill. Making it difficult to accurately dose and treat the patient, which leads to ineffective treatment, medication waste, and significant patient compliance issue. SGC provides a perfect solution for these problems. Building upon its proprietary API-Complexing technology and sugar-free GUMMY ZERO® matrix protected by a large and robust IP portfolio, the company has developed stable and great tasting gummy drugs treating varieties of diseases. With the initial focus on pediatric and geriatric markets, SGC’s current drug development program features a suite of gummy drugs for treating allergy, pain, fever, cough, nausea, insomnia, inflammatory, cardiovascular conditions, and bacterial infection. The company has a diverse gummy drug pipeline in the regulatory approval process and has received the FDA approval for its IND of the very first gummy drug formulation in the world.

SinusPharmacy Corp. provides intranasal nebulized therapies for the treatment of chronic sinusitis. The company is headquartered in Carpinteria, CA.

Laboratorios Senosiain SA de CV engages in the development and manufacture of pharmacetical products. These include antibiotics, suppositories, and analgesics. The company is based in Mexico City, Mexico.

NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada.

MEDA Pharma is a company that provides healthcare services to people of high quality with safety. A medium-sized pharmaceutical company, Madaus GmbH belongs to the worldwide operating Meda Group. They manufacture pharmaceuticals as well as scientifically based health products such as medical devices, cosmetics, and dietary supplements. Its mission was to set new standards for health care, give 7 billion people access to high-quality medicine, and carry out research to address unmet healthcare needs.

R.P. Scherer GmbH & Co. KG, part of Catalent, Inc., is a company headquartered in Eberbach, Germany, that develops, manufactures and sells pharmaceutical products.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Aventis Pharmaceuticals is a pharmaceutical company manufacturing drugs for a variety of diseases and disorders. The company is based in India and manufactures drugs for cardiovascular, thrombotic, metabolic disorders, oncology and disorders of the nervous system. The company was the world’s first pharmaceutical company to market an insulin drug for daily use.   The company was founded in 1956 as Hoechst Fedco Pharma. The company is now part of the Sanofi-Aventis group.